These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37953607)

  • 21. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
    Ibáñez L; de Zegher F
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals.
    Caanen MR; Schouten NE; Kuijper EAM; van Rijswijk J; van den Berg MH; van Dulmen-den Broeder E; Overbeek A; van Leeuwen FE; van Trotsenburg M; Lambalk CB
    Hum Reprod; 2017 Jul; 32(7):1457-1464. PubMed ID: 28505246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test.
    Rosenfield RL; Mortensen M; Wroblewski K; Littlejohn E; Ehrmann DA
    Hum Reprod; 2011 Nov; 26(11):3138-46. PubMed ID: 21908468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.
    Hirschberg AL
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1243-1253. PubMed ID: 36409990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sexual function in women with androgen excess disorders: classic forms of congenital adrenal hyperplasia and polycystic ovary syndrome.
    Kępczyńska-Nyk A; Kuryłowicz A; Nowak A; Bednarczuk T; Ambroziak U
    J Endocrinol Invest; 2021 Mar; 44(3):505-513. PubMed ID: 32557272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of androgens in women with hypoactive sexual desire disorder: those on combined oral contraceptives (COCs) vs. those not on COCs.
    Warnock JK; Clayton A; Croft H; Segraves R; Biggs FC
    J Sex Med; 2006 Sep; 3(5):878-882. PubMed ID: 16942531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dermatology of androgen-related disorders.
    Essah PA; Wickham EP; Nunley JR; Nestler JE
    Clin Dermatol; 2006; 24(4):289-98. PubMed ID: 16828411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of hyperandrogenism and obesity on mindfulness and metacognition in adolescents with polycystic ovary syndrome.
    Kara O; Kaymaz N; Uzun ME
    Arch Womens Ment Health; 2022 Oct; 25(5):911-921. PubMed ID: 36074275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome.
    Hahn S; Kuehnel W; Tan S; Kramer K; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE
    Clin Chem Lab Med; 2007; 45(2):202-7. PubMed ID: 17311509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polycystic Ovary Syndrome among Obese Adolescents.
    Ybarra M; Franco RR; Cominato L; Sampaio RB; Sucena da Rocha SM; Damiani D
    Gynecol Endocrinol; 2018 Jan; 34(1):45-48. PubMed ID: 28758509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral contraceptives and the management of hyperandrogenism-polycystic ovary syndrome in adolescents.
    Hillard PJ
    Endocrinol Metab Clin North Am; 2005 Sep; 34(3):707-23, x. PubMed ID: 16085167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained Maternal Hyperandrogenism During PCOS Pregnancy Reduced by Metformin in Non-obese Women Carrying a Male Fetus.
    Andræ F; Abbott D; Stridsklev S; Schmedes AV; Odsæter IH; Vanky E; Salvesen Ø
    J Clin Endocrinol Metab; 2020 Dec; 105(12):3762-70. PubMed ID: 32866967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.
    Escobar-Morreale HF
    Nat Rev Endocrinol; 2018 May; 14(5):270-284. PubMed ID: 29569621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The serum steroid signature of PCOS hints at the involvement of novel pathways for excess androgen biosynthesis.
    Altinkilic EM; du Toit T; Sakin Ö; Attar R; Groessl M; Flück CE
    J Steroid Biochem Mol Biol; 2023 Oct; 233():106366. PubMed ID: 37499841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Menstrual irregularity in the first postmenarchal years: an early clinical sign of polycystic ovary syndrome in adolescence.
    Avvad CK; Holeuwerger R; Silva VC; Bordallo MA; Breitenbach MM
    Gynecol Endocrinol; 2001 Jun; 15(3):170-7. PubMed ID: 11447727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of community-based reference ranges to estimate the prevalence of polycystic ovary syndrome by the recognised diagnostic criteria, a cross-sectional study.
    Skiba MA; Bell RJ; Herbert D; Garcia AM; Islam RM; Davis SR
    Hum Reprod; 2021 May; 36(6):1611-1620. PubMed ID: 33846715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Androgen excess: a hallmark of polycystic ovary syndrome.
    Wang K; Li Y; Chen Y
    Front Endocrinol (Lausanne); 2023; 14():1273542. PubMed ID: 38152131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
    Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
    Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies.
    Xita N; Tsatsoulis A
    J Clin Endocrinol Metab; 2006 May; 91(5):1660-6. PubMed ID: 16522691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.